Paper4040355
Intolerance to cisplatin--a case report.
Umbach GE and 3 others. Arch Gynecol, 1985. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Intolerance to cisplatin--a case report. Papers, record 4040355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4040355
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Drug Hypersensitivity | Major topic |
| Drug Tolerance | |
| Female | |
| Humans | |
| Middle Aged |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 387223 | Toxic effects of cis-dichlorodiammineplatinum(II) in man. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/387223 | PubMed |
| 2 | 856437 | High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. | Cancer | 1977 | https://conductscience.org/library/papers/856437 | PubMed |
| 3 | 7188679 | Toxicity of cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydration. | Cancer | 1980 | https://conductscience.org/library/papers/7188679 | PubMed |
| 4 | 291484 | Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/291484 | PubMed |
| 5 | 574057 | Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/574057 | PubMed |
| 6 | 91439 | Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/91439 | PubMed |
| 7 | 7004302 | Hypersensitivity reactions to cancer chemotherapeutic agents. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/7004302 | PubMed |
| 8 | 4187030 | Platinum and platinosis. Allergy and histamine release due to some platinum salts. | Arch Environ Health | 1969 | https://conductscience.org/library/papers/4187030 | PubMed |
| 9 | 50881 | Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes. | Cancer Res | 1975 | https://conductscience.org/library/papers/50881 | PubMed |
| 10 | 87272 | Successful re-treatment with cis-dichlorodiammineplatinum(II) after apparent allergic reactions. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/87272 | PubMed |
| 11 | 6455280 | [Non allergic skin reactions of drugs (author's transl)]. | Derm Beruf Umwelt | 1981 | https://conductscience.org/library/papers/6455280 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4040355
GET https://conductscience.org/api/papers/v1/4040355/authors